↓ Skip to main content

Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?

Overview of attention for article published in Pharmaceutical Medicine, January 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
35 Mendeley
Title
Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?
Published in
Pharmaceutical Medicine, January 2019
DOI 10.1007/s40290-018-00262-z
Pubmed ID
Authors

Stanton R. Mehr, Richard A. Brook

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 20%
Student > Ph. D. Student 5 14%
Student > Master 5 14%
Researcher 4 11%
Student > Doctoral Student 3 9%
Other 3 9%
Unknown 8 23%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 9 26%
Medicine and Dentistry 4 11%
Economics, Econometrics and Finance 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Veterinary Science and Veterinary Medicine 2 6%
Other 6 17%
Unknown 9 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2019.
All research outputs
#13,946,643
of 23,124,001 outputs
Outputs from Pharmaceutical Medicine
#88
of 151 outputs
Outputs of similar age
#223,923
of 438,225 outputs
Outputs of similar age from Pharmaceutical Medicine
#1
of 3 outputs
Altmetric has tracked 23,124,001 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 151 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,225 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them